Drug Profile
SEL 068
Alternative Names: Immunomodulatory nanoparticle vaccine for smoking cessation - Cartesian Therapeutics; SEL-068; tSVP™ for smoking cessation and relapse prevention - Cartesian TherapeuticsLatest Information Update: 05 Dec 2023
Price :
$50
*
At a glance
- Originator Selecta Biosciences
- Developer Cartesian Therapeutics
- Class Drug withdrawal therapies; Smoking cessation therapies; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Smoking withdrawal
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Smoking-withdrawal(Prevention of relapse, In volunteers) in Belgium (SC, Injection)
- 06 May 2014 Selecta Biosciences completes a phase I trial in in volunteers for Smoking withdrawal in Belgium (NCT01478893)
- 21 Nov 2011 Phase-I clinical trials in Smoking withdrawal in Belgium (SC)